75N91019F00138

CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number: 75N91019F00138
Issuing organization: National Institutes of Health · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
Source: USASpending (Federal)
Source ID: usa-75N91019F00138

Details

Location: United States

Description

CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS Awarded to: LEIDOS BIOMEDICAL RESEARCH INC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DELIVERY ORDER

Dates

Publication: 2019/09/23 12:00:00 AM UTC
Closing date: 2029/09/18 12:00:00 AM UTC

Estimated value

$24.1M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-09-02, 12:11:30 p.m.

Data refreshed every 2 hours